Argenx
ARGX
$372.80
Share price
1.14%
Change (1 day)
-2.62%
Change (1 year)
Categories
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.
Argenx (ARGX) - Net assets
Net assets on the balance sheet as of December 2023 : $4.09 B
According to Argenx
's latest financial reports the company has $4.09 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Argenx - Net assets on balance sheet (from 2021 to 2020)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $2.81 B | 11.03% |
| 2021-12-31 | $2.53 B | 23.08% |
| 2020-12-31 | $2.05 B | 55.72% |
| 2019-12-31 | $1.32 B | 87.68% |
| 2018-12-31 | $0.70 B | 41.82% |
| 2017-12-31 | $0.49 B | 608.04% |
| 2016-12-31 | $70.16 M | 57.45% |
| 2015-12-31 | $44.56 M | -39.83% |
| 2014-12-31 | $74.06 M | 78.94% |
| 2013-12-31 | $41.39 M | 87.92% |
| 2012-12-31 | $22.02 M | -39.08% |
| 2011-12-31 | $36.15 M | 165.65% |
| 2010-12-31 | $13.61 M |